Futuremed Healthcare Income Fund

Futuremed Healthcare Income Fund

September 29, 2010 17:46 ET

Futuremed Announces New Strategic Partnership

CONCORD, ONTARIO--(Marketwire - Sept. 29, 2010) - Futuremed Healthcare Income Fund (TSX:FMD.UN) ("Futuremed" or the "Fund") announced today that it has entered into an exclusive, long-term strategic partnership with KCI Canada to market and sell KCI's high quality Negative Pressure Wound Therapy (NPWT) and Therapeutic Surface products to the Canadian long-term care sector. Futuremed will be responsible for the sales, service and distribution of KCI products in this growing market segment.

"We are very pleased to be entering this key strategic relationship with KCI Canada," commented Raymond Stone, President and CEO. "Not only will we be adding a new line of well known and well-respected products to our offering, we have joined forces with a market leader to leverage our industry leading customer base and extensive distribution network. It's a win for Futuremed , KCI Canada and our customers."

"We've combined KCI's proven healing technologies and Futuremed's outstanding long term care relationships," said John Simmons , KCI Canada's Vice President and General Manager. "This is a great win for patients – a partnership that improves accessibility of quality healthcare therapies for Canadians."

About Futuremed Healthcare Income Fund

Futuremed Healthcare Income Fund, through its operating entities, is Canada's leading value-added distributor of consumable nursing home supplies and specialized furniture and equipment to the growing long-term care facilities sector. Futuremed's Trust Units trade on the Toronto Stock Exchange under the symbol FMD.UN. More information can be found at www.futuremed.ca.

About KCI

Kinetic Concepts, Inc. (NYSE:KCI), a leading global medical technology company devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets. Headquartered in San Antonio, Texas, KCI's success spans more than three decades and is deeply rooted in a legacy of innovation and a passion for significantly improving the healing and the lives of patients around the world. The Company employs 6,800 people and markets its products in 20 countries. For more information about KCI and how its products are changing the practice of medicine, visit www.KCI.com.

This document may contain forward-looking statements relating to Futuremed's operations or to the environment in which it operates, which are based on the Fund's operations, estimates, forecasts and projections. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict, and/or are beyond the Fund's control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. These factors include those set forth in other public filings. In addition, these forward-looking statements relate to the date on which they are made. The Fund disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. More information about these risks and uncertainties can be found in regulatory filings available at www.sedar.com.

Contact Information

  • Futuremed Healthcare Income Fund
    Daniel Sacks
    Chief Financial Officer
    (905) 761-0068, ext. 2222
    Toll-free investor relations: 1-800-387-7025